US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028: US$ 85 Billion Market Opportunity by 2028
March 17, 2022 06:58 ET
|
Research and Markets
Dublin, March 17, 2022 (GLOBE NEWSWIRE) -- The "US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. In...
Global Biologics CDMO Market Report 2022: A Market Valued at $9.9 Billion in 2020 - Competitive Developments, Strategies, Mergers and Acquisitions & New Product Developments to 2026
February 15, 2022 07:18 ET
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Global Biologics CDMO Market (2022 Edition) - Analysis By Type (Mammalian, Non-Mammalian), Product Type (Biologics, Biosimilars), By Region, By...
Insights on the Antibody Drugs Technologies and Global Markets to 2026
November 23, 2021 06:03 ET
|
Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drugs: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for antibody...
Masked Antibodies & Cytokines Landscape 2021 - Profiles of Key Stakeholders in Masking Technologies
October 08, 2021 08:43 ET
|
Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry...
Global Pharma, Biotech & Diagnostics Licensing Partnering Terms & Agreements Report 2021
July 15, 2021 04:08 ET
|
Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2021" report has been added to ResearchAndMarkets.com's...
Vectorized Antibodies for In Vivo Expression Industry - Featuring Adverum Biotechnologies, Homology Medicines and BioNTech Among Others
July 13, 2021 04:53 ET
|
Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from...
Global Antibody Partnering Deals, Terms and Agreements Report 2021
June 11, 2021 05:38 ET
|
Research and Markets
Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Partnering Terms and Agreements 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Global Antibody Partnering...
Global Cancer Monoclonal Antibody Partnering Deals Directory 2020: Access to Over 500 Cancer Monoclonal Antibody Deal Records Since 2014
February 05, 2021 07:08 ET
|
Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Antibody Partnering Terms and Agreements Directory 2020: Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target
February 05, 2021 06:53 ET
|
Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Partnering Terms and Agreements 2014-2020" report has been added to ResearchAndMarkets.com's offering. The Global Antibody Partnering...
Global Monoclonal Antibody Partnering Directory 2014-2020: Monoclonal Antibodies, Murine mAb, Chimeric mAb, Humanized mAb, Human aAb
September 24, 2020 05:09 ET
|
Research and Markets
Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020" report has been added to ResearchAndMarkets.com's offering. The Global...